Severity of Autism Spectrum Disorder Symptoms Associated with de novo Variants and Pregnancy-Induced Hypertension.
Xiaomeng WangZhengbao LingTengfei LuoQiao ZhouGuihu ZhaoBin LiKun XiaJin-Chen LiPublished in: Journal of autism and developmental disorders (2022)
Genetic factors, particularly, de novo variants (DNV), and an environment factor, exposure to pregnancy-induced hypertension (PIH), were reported to be associated with risk of autism spectrum disorder (ASD); however, how they jointly affect the severity of ASD symptom is unclear. We assessed the severity of core ASD symptoms affected by functional de novo variants or PIH. We selected phenotype data from Simon's Simplex Collection database, used genotypes from previous studies, and created linear regression models. We found that ASD patients carrying DNV with PIH exposure had increased adaptive and cognitive ability, decreased social problems, and enhanced repetitive behaviors; however, there was no difference in patients without DNV between those with or without PIH exposure. In addition, the DNV genes carried by patients exposed to PIH were enriched in ubiquitin-dependent proteolytic processes, highlighting how candidate genes in pathways and environments interact. The results indicate the joint contribution of DNV and PIH to ASD.
Keyphrases
- autism spectrum disorder
- end stage renal disease
- attention deficit hyperactivity disorder
- newly diagnosed
- intellectual disability
- chronic kidney disease
- ejection fraction
- blood pressure
- copy number
- mental health
- healthcare
- peritoneal dialysis
- emergency department
- gene expression
- patient reported outcomes
- small molecule
- pregnant women
- physical activity
- oxidative stress
- electronic health record
- drug induced
- artificial intelligence
- neural network
- bioinformatics analysis